A one-time CRISPR cholesterol drug cut LDL by 49% and triglycerides by 55% in the first human trial. Here’s what the Phase 1 data actually show.

The post A One-Time Infusion To Cut Cholesterol? Here’s How It Could Work. appeared first on The Hearty Soul.